Home | News | Events | Press | Contact  

About UseNewsletterMessage BoardsAction CenterAdvocateWalk to End Alzheimer’sShopDonate

Find your chapter:

search by state

In My Community

Weekly e-news

We will not share your information.

Local Research Opportunities
Text Size controlsNormal font sizeMedium font sizeLarge font size

Get Started

Already have an account? Log in.

Understanding dementia: The effects of supportive services on the perceived stress of caregivers.

The purpose of this study is to analyze and compare the supportive services available to caregivers of individuals with dementia to determine which service is associated with the lowest levels of stress. This will allow for the cultivation of a better understanding of the most effective services and may help caregivers to assess their mental health needs and find the most effective form of supportive service. Caregivers, over the age of 18, of individuals with dementia are eligible to participate in the study. Participation and responses will be held strictly confidential. Participants will not be asked to put any identification on the questionnaires however with any internet survey there is no way to guarantee absolute anonymity.

If you are a caregiver for a person with dementia, please complete the anonymous survey at the following link:


The Cleveland Clinic Lou Ruvo Center for Brain Health is currently looking for healthy older adults between the ages of 60 and 80 with or without a family history of Alzheimer’s Disease for a new research study.

The study will look at the effects of Donepezil HCL (Aricept) on Task-Activated fMRI brain activation. Participation will last approximately 7-8 months including 9 clinic visits and will involve 2 MRI scans, genetic testing, and evaluations of memory function.

Financial compensation will be provided.

For more information, please call:
Or email: CBHresearch@ccf.org

Phase II, Multicenter, Sixteen-Week, Randomized, Double Blind, Placebo-Controlled Evaluation of the Efficacy, Tolerability and Safety of Memantine Hydrochloride on Enhancing the Cognitive Abilities of Adolescents and Young Adults with Down Syndrome- Study Subjects Wanted

A team of medical doctors and psychologists at the Case Western Reserve University, University Hospitals, and the Cleveland Clinic is investigating the effects of memantine on individuals with Down syndrome who are between the ages 15 and 32. Memantine is a medication FDA-approved for the treatment of Alzheimer's disease, but it is not approved for use in persons with Down syndrome. This study was designed to examine whether or not this medication is safe and if it can improve memory and learning skills in adolescents and young adults with Down syndrome.

This study requires the participant and his or her primary caregiver to complete five to seven outpatient visits to University Hospitals in Cleveland, Ohio. Psychological and medical tests will take place during the visits. The tests, medication, and medical care related to the study are provided free of charge. Parking will be validated, and mileage can be reimbursed for those traveling 20 miles or more to come to the study.

If you, or someone you know, would be interested and meet the following requirements:

  • 15-32 years of age
  • medically diagnosed with Down syndrome
  • in good general health and not pregnant
  • able to swallow medicine capsules (crushing of capsules will not be permitted)
  • have a reliable caregiver or family member who agrees to come with the participant to all visits, provide information about the participant, and ensure compliance with the medication schedule
  • know enough English to be capable of reliably completing study tests

The study Principal Investigator is Alberto Costa, MD, PhD
Department of Pediatrics, Division of Pediatric Neurology
Case Western Reserve University and University Hospitals

For more information, please call or E-mail the study coordinator, Ms. Melissa Stasko (216-844-7281, Melissa.Stasko@case.edu)

Alzheimer's Disease: NeuroAD Clinical Trial

Patients may qualify for this study if they:

  • Are 60 to 90 years old
  • Have a diagnosis of dementia due to probable
  • Alzheimer's disease (AD)
  • Have a study partner willing to accompany them to all study visits and answer questions regarding the patients condition.
  • Are on a stable dose of donepezil, rivastigmine or galantamine for at least 90 days before screening and throughout the study.

The study doctor will check for other medical conditions or reasons that might prevent you from participating in the study.

The NeuroAD Study is testing a non-invasive therapeutic system designed to improve cognitive functioning through magnetic stimulation to targeted areas of the brain. In addition, cognitive training is done simultaneously using a interactive video screen. It is a 15 week program consisting of daily 1 hour appointments, five days a week for 6 weeks; two screening visits including an MRI; and two follow up visits, one at 7 weeks and the other at 12 weeks.

If you are interested in participating or would like additional information, please contact the study coordinator, Christine Whitman, RN.

216.227.2438 or whitmac@ccf.org

Families Affected by Dementia

Do you have a relative who is 60 years or older with dementia or age-related memory impairment?

Are you a live-in, unpaid caregiver for this family member?

If so, you may be eligible to participate in a telephone survey. Upon completion of the survey, you will be compensated $40 for your time.

Call the Aging Family Project University of Miami
(305) 284-5455 Dr. Amy G. Weisman de Mamani


Have increasing forgetfulness or difficulty thinking, or concerned you may have Alzheimer’s disease?

Current available medications help manage symptoms but do not slow the course of Alzheimer’s disease.  Through ongoing clinical research, doctors evaluate study drugs that may control symptoms and, may possibly help with disease management.

We are evaluating the effectiveness and safety of an oral study drug that may help slow or stop the progression of Alzheimer’s Disease.

To be considered for study participation, you must:

  • Be 50 to 85 years old
  • Have symptoms of worsening memory or thinking problems of the past year.
  • Have a partner or caregiver willing to accompany  you to study visits and help you follow study requirements
  • Other eligibility requirements apply.

All study-related drugs and care will be provided at no cost. 
This study is being conducted at Insight Clinical Trials LLC. 

Please contact Elisa @ (216) 832-6606 or
www.InsightClinicalTrials.com for further information

Research Study seeks interested Individuals at least 70 years old with no memory problems or with mild to moderate memory problems are invited to take part in a research study.*

  • The study involves 2 visits spaced 12 months apart.
  • Each visit will last approximately 2 hours and will involve questions about you and your health.
  • There are no invasive procedures or medications.
  • Participants will receive a stipend after completing each study visit.
  • Study participants need to be able to read and speak English and complete written questionnaires.

    *This includes those diagnosed with Mild Cognitive Impairment
    or early Alzheimer’s disease.

Drs. Kathleen Smyth and Martha Sajatovic of the Neurological Outcomes Center are the study’s Principal Investigators. The goal of this study is to find the best way to measure the effects of future treatments to improve physical and mental function of older adults.

The study is funded by the National Institutes of Health.

For more information please contact
Nancy 216-368-2668 Nancy.Catalani@case.edu

Clinical Study

*endorsed by Greater Michigan Chapter MSAC

Cyndi Hovland-Scafe, former Family Services Manager for the Greater Michigan Chapter and social work student at the University of Wisconsin-Madison, is exploring caregivers' experiences with the death of a family member from a dementia-related diagnosis.  It is hoped that the results of this study will help professionals to understand better the physical, emotional, social and spiritual needs of family members caring for a loved one at the end of his or her life.

  • Did you provide care to a family member age 65 or older who died from dementia within the past 6-18 months?

If so, would you be willing to share your experiences with Cyndi?  To participate in this study, Cyndi would meet with you at your home or other convenient location for a 60-90 minute interview.  For more information or to volunteer please contact:
Cyndi Hovland-Scafe

Letter of Request

Alzheimer’s Disease & Cataract Removal Research Study

University Hospitals Case Medical Center, the MetroHealth Medical System, and Case Western Reserve University are now enrolling patients in a new, 5-year research study sponsored by the National Institutes of Health. 

In the study, we will learn more about how cataract removal impacts Alzheimer’s disease patients in their daily activities, their quality of life, their mood, and their performance on memory, cognitive, and visual tasks.

The duration of the study for each Participant will be approximately 6 months.  All study Participants will first be screened to determine if they are eligible and then randomly selected into one of two groups: Group A (immediate surgery group), or Group B (delayed surgery group).  Group A will have their cataract surgery within 1 month of enrolling in the study.  Group B will be asked to delay their cataract surgery for 6 months.

To be eligible, you must be at least 50 years or older, have a diagnosis of Alzheimer’s disease, have cataracts in both eyes, and know someone who can act as your “study partner.” 

To learn more about this study, please contact the University Hospitals Study Coordinator, Tatiana Riedel at 216-368-6465, (e-mail tjm6@case.edu), or the MetroHealth Study Coordinator, Alicia O’Brien at 216-778-2461 (e-mail aobrien@metrohealth.org).

Participants needed for
Center for Brain Health Study

Are you generally healthy, between the ages of 60 and 85, and have had a family member diagnosed with Alzheimer’s Disease? If so, you may be eligible for a new study being conducted at the Lou Ruvo Cleveland Clinic Center for Brain Health.

Please download the following 2 PDFs for more information about the study and how to participate 

    Click Here for a printable flyer         Click Here for  printable Brochure




Alzheimer's Association

Our vision is a world without Alzheimer's
Formed in 1980, the Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research.